Anti-Interleukin 23 Biologic Are Mostly Effective and Safe in Psoriatic Patients Who Failed Anti-Interleukin 17. A Real-Life, Retrospective 52-Week Experience
- Arroyo-Andrés, J.
- Falkenhain-López, D.
- Agud-Dios, M.
- Rivera-Díaz, R.
ISSN: 1578-2190, 0001-7310
Year of publication: 2023
Volume: 114
Issue: 4
Pages: T363-T365
Type: Article